News | Stents Drug Eluting
Biotronik announced publication of results from the BIOSCIENCE trial in the journal EuroIntervention. The study’s authors suggest the Orsiro hybrid drug-eluting stent (DES) may have an advantage over Xience Prime/Xpedition in treating ST-segment elevation myocardial infarction (STEMI) patients. STEMI is a potentially fatal type of heart attack caused by a prolonged obstruction of blood supply in the heart. Every year nearly 250,000 people experience STEMI heart attacks.
March 07, 2016
News | Heart Valve Technology
Women undergoing transcatheter aortic valve replacement (TAVR) have better survival rates than men at one year, according to a study published in Annals of Internal Medicine. These results are the opposite of those seen in surgical aortic valve replacement (SAVR), for which female sex has been shown to be associated with poorer outcomes.
March 07, 2016
Technology | Stent Grafts
At the Houston Aortic Symposium, W. L. Gore & Associates, Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) approval of the Gore Excluder Iliac Branch Endoprosthesis (IBE). The approval makes it the first off-the-shelf aortic branch device approved in the United States and the only device indicated for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms.
March 07, 2016Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Heart Valve Technology
Medtronic plc announced the first patients enrolled in the Evolut R FORWARD Clinical Study to evaluate performance outcomes using the CoreValve Evolut R System in everyday clinical practice.
March 07, 2016
Technology | Leads Implantable Devices
March 4, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Acuity X4 ...
March 04, 2016
News | Cath Lab
Recent results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) are evidence that stenting will continue to remain competitive with surgical treatment, said an analyst with research and consulting firm GlobalData. CREST data has shown patients with severe carotid artery stenosis suffered similar rates of adverse events in both stenting and endarterectomy procedures.
March 04, 2016Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology | Stent Grafts
W. L. Gore & Associates (Gore) announced the availability of a new 7.5 cm length of the Gore Viabahn Endoprosthesis with heparin bioactive surface. Gore developed this size in response to physician needs for certain clinical situations. The device is now available in six lengths: 2.5, 5, 7.5, 10, 15 and 25 cm.
March 04, 2016
News | Stroke
Brain imaging may accurately identify patients likely to benefit from stroke clot removal instead of relying on the time since symptoms began as an indicator of treatment eligibility. The hypothesis was derived from research presented at the American Stroke Association's International Stroke Conference 2016.
March 04, 2016
News | Congenital Heart
Last August, Children’s Hospital Los Angeles (CHLA) cardiologists confirmed the heart of a 27-week-old fetus suffered from a critical cardiac condition that prevented blood returning from the fetus’s lungs from circulating back into the body.
March 03, 2016Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology | Wearables
Vital Connect debuted the VitalPatch biosensor at the 2016 Healthcare Information and Management Systems Society (HIMSS) conference and exhibition, Feb. 29-March 4 in Las Vegas.
March 03, 2016
Technology | Atherectomy Devices
Avinger Inc. announced the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an enhanced version of its Pantheris lumivascular atherectomy system for the treatment of peripheral artery disease (PAD).
March 03, 2016
Technology | Telecardiology
Philips announced four leading U.S. health systems have signed multi-year telehealth deals to implement the company’s remote intensive care unit (eICU) program.
March 03, 2016Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Clinical Decision Support
IBM Watson Health announced plans Feb. 18 to acquire Truven Health Analytics, a leading provider of cloud-based healthcare data, analytics and insights, for $2.6 billion. Truven will bring more than 8,500 clients, including U.S. federal and state government agencies, employers, health plans, hospitals, clinicians and life sciences companies, to the IBM Watson Health portfolio.
March 02, 2016Technology | Wearables
Philips announced that it will introduce a next-generation monitoring solution for at-risk patients in low-acuity hospital settings, such as the general ward.
March 02, 2016
News | Analytics Software
GE Healthcare announced two large systems integrators (SIs) and seven leading-edge independent software vendors (ISVs) are planning to move their digital solutions to the new GE Health Cloud. Designed exclusively for the healthcare industry and resting on the shoulders of GE’s Predix platform, the GE Health Cloud will ultimately connect more than 2 million imaging machines worldwide, including 500,000 GE Healthcare devices.
March 02, 2016© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now